Skip to content
zameds

Aluminium hydroxide, magnesium hydroxide, magnesium trisilicate

Sold as Norigel wafers, Gelusil m, Gelusil m liquid

Every registration of this product has been cancelled.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
2
Registrations
3

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Hoechst Marion Roussel LtdCancelledNorigel wafersNot statedE0138Not determinedNone
Johnson & Johnson (Pty) Ltd û East LondonCancelledGelusil m, Gelusil m liquidtabletsF0135, F0136Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Norigel wafers

EACH WAFER CONTAINS ALUMINIUM HYDROXIDE GEL 20 % MAGNESIUM HYDROXIDE GEL 20 % MAGNESIUM TRISILICATE GEL 60 %

Not listedE0138E/11.4.1/138CancelledNot determinedNone
Gelusil m tablets

EACH TABLET CONTAINS ALUMINIUM HYDROXIDE 250 mg MAGNESIUM HYDROXIDE 100 mg MAGNESIUM TRISILICATE 500 mg

TabletsF0135F/11.4.1/135CancelledNot determinedNone
Gelusil m liquid

EACH 5 ml CONTAINS ALUMINIUM HYDROXIDE 267 mg MAGNESIUM HYDROXIDE 104 mg MAGNESIUM TRISILICATE 515 mg

Not listedF0136F/11.4.1/136CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles